1 |
Madeddu P. Cell therapy for the treatment of heart disease: Renovation work on the broken heart is still in progress. Free Radical Biology and Medicine 2021;164:206-22. [DOI: 10.1016/j.freeradbiomed.2020.12.444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Faulkner A. Trans-endothelial trafficking of metabolic substrates and its importance in cardio-metabolic disease. Biochem Soc Trans 2021;49:507-17. [PMID: 33616631 DOI: 10.1042/BST20200991] [Reference Citation Analysis]
|
3 |
Jin W, Chen X, Kong L, Huang C. Gene therapy targeting inflammatory pericytes corrects angiopathy during diabetic wound healing. Front Immunol 2022;13:960925. [DOI: 10.3389/fimmu.2022.960925] [Reference Citation Analysis]
|
4 |
Gu Y, Rampin A, Alvino VV, Spinetti G, Madeddu P. Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy. Curr Diab Rep 2021;21:11. [PMID: 33651185 DOI: 10.1007/s11892-021-01378-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Bayliak MM, Lushchak VI. Pleiotropic effects of alpha-ketoglutarate as a potential anti-ageing agent. Ageing Res Rev 2021;66:101237. [PMID: 33340716 DOI: 10.1016/j.arr.2020.101237] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
|
6 |
Rampin A, Carabba M, Mutoli M, Eman CL, Testa G, Madeddu P, Spinetti G. Recent advances in KEAP1/Nrf2-targeting strategies by phytochemical antioxidants, nanoparticles, and biocompatible scaffolds for the treatment of diabetic cardiovascular complications. Antioxid Redox Signal 2022. [PMID: 35044251 DOI: 10.1089/ars.2021.0134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|